Work

Abstract 1535: Development of a fluorescent analog of BCR-ABL kinase inhibitor, Tasigna® (AMN-107, nilotinib) to study its interaction with ABC drug transporters

Year: 2010

Type: conference-abstract

Source: Cancer Research

DOI: 10.1158/1538-7445.am10-1535

Authors: Suneet Shukla, Amanda P. Skoumbourdis, Chung-Pu Wu, Anika M.s. Hartz, Björn Bauer, Craig J. Thomas, Suresh V. Ambudkar

Institutions: National Cancer Institute, National Institutes of Health, University of Minnesota, Duluth

Language: English

Topic: Drug Transport and Resistance Mechanisms

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2320139669

Cites:

Cited by:

Related to: 10